Researchers have identified a dual therapeutic strategy that combined inhibition of a key SARS-CoV-2 viral enzyme with suppression of a host inflammatory pathway, with preclinical evidence that ...

Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the immune system. Instead of harmless debris, new research suggests these ...

The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the ...

"We really don't know how that happened." Scientists stunned after virus jumps between humans and animals: 'It was a very unusual situation' first appeared on The Cool Down.

C OVID-19 may leave a lasting impression on the brain, even in people who fully recover from their infection. New research ...

Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.

The US FDA has approved two companies’ COVID vaccines that target the latest variant of the virus for adults aged at least 65 years and individuals at high risk for severe outcomes, according to ...

A virus-agnostic nasal spray called ‘INNA-051’ was designed to increase innate immunity and prevent respiratory illnesses ...